Results per Page:
Fred Hutch Phase 1 Program director, Dr. John Thompson, retires
An immunotherapy champion, Thompson co-led the melanoma clinic for decades
7 skin cancer myths — debunked
Experts take on base tans and other ‘complete baloney’ standing in the way of skin health
Good News: Malik and Bloom win ASM awards; pilot project funded by Bezos family aims to create personalized anticancer vaccines
Celebrating faculty and staff achievements
Cancer Immunotherapy Trials Network selects member sites
Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies
SCCA opens Northwest’s first academic phase 1 Clinical Trials Unit
Facility will increase earlier access to promising new drugs
Encouraging results for renal-cell cancer trial
An international team of investigators report progression-free survival in patients treated with IL-21 combined with Nexavar after failure of prior therapy